News

Lumen Bio: ‘We face 2023 with tremendous optimism’

Lumen Bio: ‘We face 2023 with tremendous optimism’

BIOPHARMA REPORTER | Lumen Bioscience has been highlighting recent progress made on its clinical and regulatory journey while also announcing several funding milestones supporting the development of its therapeutics to prevent serious diarrheal diseases.

Full Story